🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Treatment Gaining Traction Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to message these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Vendors promote the drug there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in users administering substances of uncertain source.

Several experts said the popularity for the experimental drug could be linked to the increasing cost of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.

Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, marketing, and customer regulations, risking penalties, legal action or prison.

Service Response and Content Elimination

Based on the social media company, the service has removed problematic material and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and investing in strengthening enforcement strategies.

Digital Trading Activities

Investigations also found communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at home.

After moments of entering one group, a vendor posted WhatsApp details, where most transactions occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Details and Costs

Inside these groups, messages show dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When asked how much time a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they can’t verify. Although the research behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has already encountered individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to possibly significant health risks”.